These results thus demonstrated for the first time that epacadostat treatment of DCs prior to peptide-pulsing resulted in both increased cytokine production and increased tumor cell lysis by antigen-specific CD8+ T-cell lines derived from cancer patients. This evidence concerns the gene CD8A and cancer.